Advertisement
Advertisement
U.S. Markets open in 6 hrs
Advertisement
Advertisement
Advertisement
Advertisement

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
42.38+0.91 (+2.19%)
At close: 04:00PM EST
42.47 +0.09 (+0.21%)
After hours: 07:59PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 343.61
52 Week Low 333.53
50-Day Moving Average 340.68
200-Day Moving Average 339.15

Share Statistics

Avg Vol (3 month) 34.32M
Avg Vol (10 day) 33.6M
Shares Outstanding 52.52B
Implied Shares Outstanding 6N/A
Float 82.45B
% Held by Insiders 10.01%
% Held by Institutions 112.64%
Shares Short (Jun 14, 2021) 418.63M
Short Ratio (Jun 14, 2021) 44.81
Short % of Float (Jun 14, 2021) 4N/A
Short % of Shares Outstanding (Jun 14, 2021) 40.74%
Shares Short (prior month May 13, 2021) 423.6M

Dividends & Splits

Forward Annual Dividend Rate 42.17
Forward Annual Dividend Yield 45.41%
Trailing Annual Dividend Rate 30.80
Trailing Annual Dividend Yield 31.93%
5 Year Average Dividend Yield 45.22
Payout Ratio 476.60%
Dividend Date 3Jan 12, 2022
Ex-Dividend Date 4May 19, 2021
Last Split Factor 22:1
Last Split Date 3Nov 11, 1991

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 16.21%
Operating Margin (ttm)23.63%

Management Effectiveness

Return on Assets (ttm)5.90%
Return on Equity (ttm)29.04%

Income Statement

Revenue (ttm)32.43B
Revenue Per Share (ttm)13.02
Quarterly Revenue Growth (yoy)-18.40%
Gross Profit (ttm)23.21B
EBITDA 9.72B
Net Income Avi to Common (ttm)5.26B
Diluted EPS (ttm)2.91
Quarterly Earnings Growth (yoy)-31.40%

Balance Sheet

Total Cash (mrq)4.82B
Total Cash Per Share (mrq)1.93
Total Debt (mrq)26.22B
Total Debt/Equity (mrq)124.79
Current Ratio (mrq)0.91
Book Value Per Share (mrq)5.94

Cash Flow Statement

Operating Cash Flow (ttm)7.81B
Levered Free Cash Flow (ttm)8.9B
Advertisement
Advertisement